Detection of T lymphocyte subsets and related functional molecules in follicular fluid of patients with polycystic ovary syndrome

[1]  S. Garzon,et al.  Inositol in Polycystic Ovary Syndrome: Restoring Fertility through a Pathophysiology-Based Approach , 2018, Trends in Endocrinology & Metabolism.

[2]  M. Noventa,et al.  Myo-inositol supplementation reduces the amount of gonadotropins and length of ovarian stimulation in women undergoing IVF: a systematic review and meta-analysis of randomized controlled trials , 2018, Archives of Gynecology and Obstetrics.

[3]  A. Al-Qtaitat,et al.  Insulin resistance and obesity among infertile women with different polycystic ovary syndrome phenotypes , 2017, Scientific Reports.

[4]  Jianbing Mu,et al.  A Schistosoma japonicum Infection Promotes the Expansion of Myeloid-Derived Suppressor Cells by Activating the JAK/STAT3 Pathway , 2017, The Journal of Immunology.

[5]  A. Tang,et al.  Detection of dendritic cells and related cytokines in follicular fluid of patients with polycystic ovary syndrome , 2017, American journal of reproductive immunology.

[6]  Qiang Yang,et al.  IRF7 regulates the development of granulocytic myeloid-derived suppressor cells through S100A9 transrepression in cancer , 2017, Oncogene.

[7]  M. Ashrafi,et al.  Gestational Diabetes Mellitus and Metabolic Disorder Among the Different Phenotypes of Polycystic Ovary Syndrome. , 2017, Oman medical journal.

[8]  Xiaoyan Wang,et al.  Upregulation of FoxO 1 Signaling Mediates the Proinflammatory Cytokine Upregulation in the Macrophage from Polycystic Ovary Syndrome Patients. , 2017, Clinical laboratory.

[9]  S. Vitale,et al.  Evidence-Based and Patient-Oriented Inositol Treatment in Polycystic Ovary Syndrome: Changing the Perspective of the Disease , 2017, International journal of endocrinology and metabolism.

[10]  A. Lasfar,et al.  IFN-λ: A New Inducer of Local Immunity against Cancer and Infections , 2016, Front. Immunol..

[11]  H. Harris,et al.  Polycystic ovary syndrome and risk of endometrial, ovarian, and breast cancer: a systematic review , 2016, Fertility Research and Practice.

[12]  R. Granese,et al.  Metabolism and Ovarian Function in PCOS Women: A Therapeutic Approach with Inositols , 2016, International journal of endocrinology.

[13]  R. Azziz,et al.  Criteria, prevalence, and phenotypes of polycystic ovary syndrome. , 2016, Fertility and sterility.

[14]  N. Afzal,et al.  Polycystic Ovary Syndrome May Be an Autoimmune Disorder , 2016, Scientifica.

[15]  O. Triolo,et al.  Inositol’s and other nutraceuticals’ synergistic actions counteract insulin resistance in polycystic ovarian syndrome and metabolic syndrome: state-of-the-art and future perspectives , 2016, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[16]  S. Chikuma.  Basics of PD-1 in self-tolerance, infection, and cancer immunity , 2016, International Journal of Clinical Oncology.

[17]  Shangwei Li,et al.  Differential Expression Profile of Immunological Cytokines in Local Ovary in Patients with Polycystic Ovarian Syndrome: analysis by Flow Cytometry. , 2016, European journal of obstetrics, gynecology, and reproductive biology.

[18]  L. B. P. C. Sá,et al.  Polycystic Ovary Syndrome (PCOS) and Fertility , 2016 .

[19]  A. S. Laganà,et al.  Oxidative Stress during Ovarian Torsion in Pediatric and Adolescent Patients: Changing The Perspective of The Disease , 2015, International journal of fertility & sterility.

[20]  B. de Courten,et al.  Sympathetic activation and endothelial dysfunction in polycystic ovary syndrome are not explained by either obesity or insulin resistance , 2015, Clinical endocrinology.

[21]  L. Friboulet,et al.  State of the art and future perspectives , 2015, Therapeutic Strategies to Overcome ALK Resistance in Cancer.

[22]  H. Teede,et al.  Polycystic ovary syndrome. , 2014, Nature reviews. Disease primers.

[23]  J. Kirwan,et al.  Glucose and lipopolysaccharide regulate proatherogenic cytokine release from mononuclear cells in polycystic ovary syndrome. , 2014, Journal of reproductive immunology.

[24]  N. Buduneli,et al.  Is interleukin-17 involved in the interaction between polycystic ovary syndrome and gingival inflammation? , 2013, Journal of periodontology.

[25]  M. Murri,et al.  Mediators of low-grade chronic inflammation in polycystic ovary syndrome (PCOS). , 2013, Current pharmaceutical design.

[26]  G. Niccoli,et al.  CD4(+)CD28(null) T lymphocyte frequency, a new marker of cardiovascular risk: relationship with polycystic ovary syndrome phenotypes. , 2012, Fertility and sterility.

[27]  M. Sammel,et al.  A decrease in serum estradiol levels after human chorionic gonadotrophin administration predicts significantly lower clinical pregnancy and live birth rates in in vitro fertilization cycles. , 2012, Human reproduction.

[28]  F. Stanczyk,et al.  Hyperandrogenism exerts an anti-inflammatory effect in obese women with polycystic ovary syndrome , 2012, Endocrine.

[29]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[30]  O. Stephansson,et al.  Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population based cohort study , 2011, BMJ : British Medical Journal.

[31]  Ricardo Azziz,et al.  Polycystic ovary syndrome: etiology, pathogenesis and diagnosis , 2011, Nature Reviews Endocrinology.

[32]  S. Yehuda,et al.  Polycystic ovary syndrome and autoimmunity. , 2010, European journal of internal medicine.

[33]  F. Orio,et al.  Pregnancy in women with polycystic ovary syndrome: the effect of different phenotypes and features on obstetric and neonatal outcomes. , 2010, Fertility and sterility.

[34]  C. Akdis.  T cells in health and disease. , 2009, The Journal of allergy and clinical immunology.

[35]  C. Benedict,et al.  Dendritic Cell Programming by Cytomegalovirus Stunts Naive T Cell Responses via the PD-L1/PD-1 Pathway1 , 2008, The Journal of Immunology.

[36]  S. Elsenbruch,et al.  Obesity, depression, and chronic low-grade inflammation in women with polycystic ovary syndrome , 2008, Brain, Behavior, and Immunity.

[37]  M. Rotondi,et al.  Role of chemokines in endocrine autoimmune diseases. , 2007, Endocrine reviews.

[38]  E. Barrett-Connor,et al.  Searching for polycystic ovary syndrome in postmenopausal women: evidence of a dose-effect association with prevalent cardiovascular disease , 2007, Menopause.

[39]  A. Nandi,et al.  Polycystic ovary syndrome , 2005, BMJ.

[40]  F. Sánchez‐Madrid,et al.  CD69 is an immunoregulatory molecule induced following activation. , 2005, Trends in immunology.

[41]  S. Kupesic,et al.  B‐ and T‐cells in the Follicular Fluid and Peripheral Blood of Patients Undergoing IVF/ET Procedures , 2004, American journal of reproductive immunology.

[42]  V. García,et al.  IL‐10 down‐regulates costimulatory molecules on Mycobacterium tuberculosis‐pulsed macrophages and impairs the lytic activity of CD4 and CD8 CTL in tuberculosis patients , 2004, Clinical and experimental immunology.

[43]  A. Volpe,et al.  Correlations between concentrations of interleukin-12 and interleukin-13 and lymphocyte subsets in the follicular fluid of women with and without polycystic ovary syndrome. , 2003, Fertility and sterility.

[44]  A. Taylor,et al.  Polycystic ovary syndrome. , 1998, Endocrinology and metabolism clinics of North America.

[45]  R. Legro,et al.  Polycystic ovary syndrome. , 1992, Current therapy in endocrinology and metabolism.

[46]  D. Anderson,et al.  Distribution of T cell subsets in follicular fluid. , 1989, Fertility and sterility.

[47]  N. Gagliani,et al.  Basic Aspects of T Helper Cell Differentiation. , 2017, Methods in molecular biology.

[48]  Cheng-Li Lin,et al.  A population-based cohort study. , 2015 .

[49]  R. Naz,et al.  Polycystic ovary syndrome: current status and future perspective. , 2014, Frontiers in bioscience.

[50]  I. Harris,et al.  A Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2010 .

[51]  E. Reinherz,et al.  Human T-cell subsets in health and disease , 2005, Springer Seminars in Immunopathology.

[52]  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. , 2004, Fertility and sterility.

[53]  B. Fauser,et al.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). , 2004, Human reproduction.

[54]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[55]  T. Janisse.  Etiology, Pathogenesis, and Diagnosis , 1991 .